324 related articles for article (PubMed ID: 10240261)
1. Will PPIs affect your patients' attitudes?
Patient Care; 1979 Feb; 13(3):190-1, 195-6. PubMed ID: 10240261
[No Abstract] [Full Text] [Related]
2. Prescription drug products; patient labeling requirements: proposed rule.
Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
[No Abstract] [Full Text] [Related]
3. Communicating with patients about their medications.
Kessler DA
N Engl J Med; 1991 Dec; 325(23):1650-2. PubMed ID: 1944456
[No Abstract] [Full Text] [Related]
4. Mandatory PPIs to begin in 1981; APhA issues strong objections.
Small WE
Am Pharm; 1980 Nov; NS20(11):10-1. PubMed ID: 7457342
[No Abstract] [Full Text] [Related]
5. Developing drug information for patients.
Hecht A
FDA Consum; 1977 Sep; 11(7):16-9. PubMed ID: 10304999
[No Abstract] [Full Text] [Related]
6. Sounding board. Creative tension: FDA and medicine.
Kennedy D
N Engl J Med; 1978 Apr; 298(15):846-50. PubMed ID: 345121
[No Abstract] [Full Text] [Related]
7. It's your health: use your medications safely.
Correa-de-Araujo R
J Womens Health (Larchmt); 2005; 14(1):16-8. PubMed ID: 15692273
[No Abstract] [Full Text] [Related]
8. Labeling regulations: 'prescribe as directed'.
Regier H
J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706
[No Abstract] [Full Text] [Related]
9. Rx with a dose of info.
Miller RW
FDA Consum; 1980 Nov; 14(9):22-3. PubMed ID: 10309292
[TBL] [Abstract][Full Text] [Related]
10. A means to provide patient education: "Rx package inserts, patient package inserts, device labeling".
Sherman M
ONA J; 1979 Aug; 6(8):326-9. PubMed ID: 257297
[No Abstract] [Full Text] [Related]
11. Unapproved uses of approved drugs: The physician, the package insert, and the FDA.
Pediatrics; 1978 Aug; 62(2):262-4. PubMed ID: 693165
[No Abstract] [Full Text] [Related]
12. The patient package insert--health care provider's friend or foe?
Hirsh HL
Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734
[No Abstract] [Full Text] [Related]
13. The legal status of patient package inserts.
Whitman JA
Hosp Formul; 1978 Oct; 13(10):789-91. PubMed ID: 10238809
[No Abstract] [Full Text] [Related]
14. Patient package inserts--instructions or intrusions?
Harvey MW
Leg Aspects Med Pract; 1978 Aug; 6(8):47-51. PubMed ID: 703481
[No Abstract] [Full Text] [Related]
15. On narrowing the patient-doctor communications gap.
FDA Consum; 1982 May; 16(4):19-21. PubMed ID: 10309635
[No Abstract] [Full Text] [Related]
16. FDA's Rx for better medication information.
Farley D
FDA Consum; 1995 Nov; 29(9):5-10. PubMed ID: 10152787
[TBL] [Abstract][Full Text] [Related]
17. Informing patients about drugs: a wrong way and a right way.
Woodson DW
Med World News; 1979 Jun; 20(13):6. PubMed ID: 10242286
[No Abstract] [Full Text] [Related]
18. FDA acts on estrogen, progestin labeling.
FDA Consum; 1977 Nov; 11(9):3. PubMed ID: 10305006
[No Abstract] [Full Text] [Related]
19. Educating patients about their medications: the potential and limitations of written drug information.
Shrank WH; Avorn J
Health Aff (Millwood); 2007; 26(3):731-40. PubMed ID: 17485751
[TBL] [Abstract][Full Text] [Related]
20. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
